CASI PHARMACEUTICALS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
CASI PHARMACEUTICALS, INC. (CASIF) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of -$251.00 thousand for the 12-month period ending 2020-12-31, per its 20-F filed 2023-04-26.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2023-04-26
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|
| 2020-12-31 | -$251.00K 20-F · filed 2023-04-26 |